Yayınlanmış 1 Ocak 2013 | Sürüm v1

The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

  • 1. Hacettepe Univ, Dept Basic Oncol, Inst Oncol, TR-06100 Ankara, Turkey
  • 2. Ankara Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey
  • 3. Izmir Inst Technol, Fac Sci, Dept Mol Biol & Genet, Izmir, Turkey

Açıklama

In chronic myeloid leukemia (CML), epigenetic modifications such as promoter hypermethylation and inactive histone modification are known mechanisms of drug resistance. In our study, we investigated the roles of promoter hypermethylation of BIM and BID genes and H3K27me3 histone modification on imatinib resistance.

Dosyalar

bib-4b443ece-1b1b-4dc6-a0a8-973e954ec987.txt

Dosyalar (234 Bytes)

Ad Boyut Hepisini indir
md5:c724c079fbb04f9c1b7ce38e17b1f655
234 Bytes Ön İzleme İndir